Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
Crossref DOI link: https://doi.org/10.1186/s12876-016-0506-4
Published Online: 2016-08-05
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kapol, Nattiya
Lochid-amnuay, Surasit
Teerawattananon, Yot
Funding for this research was provided by:
The funding was supported through the Health Intervention and Technology Assessment Program from the National Health Security Office, Thailand
License valid from 2016-08-05